Cargando…
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Patients infected with SARS-CoV-2 show a wide spectrum of clinical manifestations ranging from mild febrile illness and cough up to acute respiratory distress syndrome, multiple organ failure, and death. Data from patients with severe clinical manifestations compared to patients with mild symptoms i...
Autores principales: | Kircheis, Ralf, Haasbach, Emanuel, Lueftenegger, Daniel, Heyken, Willm T., Ocker, Matthias, Planz, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759159/ https://www.ncbi.nlm.nih.gov/pubmed/33362782 http://dx.doi.org/10.3389/fimmu.2020.598444 |
Ejemplares similares
-
COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway
por: Kircheis, Ralf, et al.
Publicado: (2021) -
Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?
por: Kircheis, Ralf, et al.
Publicado: (2022) -
The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation
por: Kircheis, Ralf, et al.
Publicado: (2023) -
Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug
por: Droebner, Karoline, et al.
Publicado: (2017) -
Arterial Response to Shear Stress Critically Depends on Endothelial TRPV4 Expression
por: Hartmannsgruber, Veronika, et al.
Publicado: (2007)